|
1909
|
A 1070722
|
Selective inhibitor of GSK-3 |
€95.00 |
|
1666
|
A 357300 hydrochloride
|
MetAP2 inhibitor |
€90.00 |
|
2944
|
A 381393
|
Potent, brain-penetrant, selective antagonist of the dopamine D4 receptor |
€125.00 |
|
1831
|
A 66
|
PI3K inhibitor (p110-α specific) |
€95.00 |
|
1466
|
A 769662
|
AMPK activator |
€85.00 |
|
1744
|
A 77-01
|
TGF-βR 1 inhibitor; ALK 5 inhibitor |
€80.00 |
|
1698
|
A 770041
|
Orally active src-family selective lck inhibitor |
€140.00 |
|
1816
|
A 784168
|
TRPV1 receptor antagonist |
€95.00 |
|
1915
|
A 803467
|
Blocker of the voltage-gated Nav1.8 channel |
€95.00 |
|
2182
|
A 804598
|
Potent and selective P2X7 antagonist |
€125.00 |
|
1421
|
A 83-01
|
TGF-βR 1 inhibitor; ALK 5 inhibitor |
€70.00 |
|
2155
|
A 841720
|
Non-competitive mGluR1 antagonist |
€85.00 |
|
2059
|
A 922500
|
Highly potent and selective diacylglycerol acyltransferase 1 (DGAT-1) inhibitor |
€105.00 |
|
1990
|
A 943931
|
H4 antagonist |
€70.00 |
|
2705
|
A-196
|
Potent and selective inhibitor of SUV4-20 |
€105.00 |
|
2720
|
A-92
|
Inhibitor of GCN2 (EIF2AK4) |
€145.00 |
|
1179
|
A1B1 hydrochloride
|
CCR1 antagonist |
€125.00 |
|
3019
|
A2764 dihydrochloride
|
Selective inhibitor of the TRESK potassium channel |
€105.00 |
|
3060
|
A2793
|
Inhibitor of the TRESK and TASK-1 potassium channel |
€95.00 |
|
3416
|
AA147
|
Endoplasmic reticulum (ER) proteostasis regulator |
€80.00 |
|
1419
|
AB 1010
|
PDGFR, c-KIT and FGFR3 tyrosine kinase inhibitor |
€70.00 |
|
3718
|
AB-680 ammonium salt
|
CD73 inhibitor |
Inquire |
|
3696
|
ABBV-075
|
Highly potent and orally bioavailable BET bromodomain (BRD) inhibitor |
€110.00 |
|
3729
|
ABBV-CLS-484 hydrochloride
|
Inhibitor of phosphatase PTPN1/N2 (Protein Tyrosine Phosphatase Non-Receptor Type 1 and 2), |
Inquire |
|
2880
|
ABC294640
|
Selective and orally available SphK2 (or SK2) inhibitor |
€125.00 |
|
3564
|
ABCA1 inducer compound G
|
ABCA1 inducer targeting OSBPL7 |
€150.00 |
|
1873
|
Abiraterone
|
Inhibitor of CYP17A1 |
€90.00 |
|
1874
|
Abiraterone acetate
|
Prodrug of Abiraterone; Inhibitor of CYP17A1 |
€90.00 |
|
3040
|
Abivertinib
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00 |
|
1235
|
Abnormal cannabidiol
|
Cannabinoid agonist |
€135.00 |